60 Degrees Pharmaceuticals, Inc. (SXTP)
NASDAQ: SXTP · Real-Time Price · USD
1.610
-0.030 (-1.83%)
At close: Jun 26, 2026, 4:00 PM EDT
1.610
0.00 (0.00%)
Pre-market: Jun 29, 2026, 7:17 AM EDT
SXTP Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for SXTP stock has a target of 3.70, which predicts an increase of 129.81% from the current stock price of 1.61.
Analyst Consensus: Buy
* Price targets were last updated on May 22, 2026.
Analyst Ratings
The average analyst rating for SXTP stock from 2 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Ascendiant | Ascendiant | Buy Maintains $4.2 → $3.7 | Buy | Maintains | $4.2 → $3.7 | +129.81% | May 22, 2026 |
| H.C. Wainwright | H.C. Wainwright | Hold Downgrades n/a | Hold | Downgrades | n/a | n/a | May 20, 2026 |
Financial Forecast
Revenue This Year
900.00K
from 1.41M
Decreased by -36.13%
Revenue Next Year
1.60M
from 900.00K
Increased by 77.78%
EPS This Year
-3.45
from -11.13
EPS Next Year
-3.58
from -3.45
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1,000,000 | 2.0M | |
| Avg | 900,000 | 1.6M | |
| Low | 800,000 | 1.2M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -29.0% | 122.2% | |
| Avg | -36.1% | 77.8% | |
| Low | -43.2% | 33.3% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | -3.45 | -3.58 | |
| Low | - | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.